Intensity modulated radiotherapy in gynecologic cancers: hope, hype or hyperbole?

Gynecol Oncol. 2013 Jul;130(1):229-36. doi: 10.1016/j.ygyno.2013.04.052. Epub 2013 Apr 28.

Abstract

Significant advances have occurred within the field of radiation oncology within the past few decades. Treatment with external beam radiotherapy has progressed from treatment fields planned from bony anatomy seen on planar X-rays, to 3-dimensional planning utilizing fused MRI's and PET images. Recently, intensity modulated radiotherapy (IMRT) has been integrated into many areas within radiation oncology, and its role in the treatment of gynecologic cancers is evolving. Potentials exist for improvements in both treatment toxicity, as well as improved efficacy through advances in treatment delivery. Unique challenges are also raised, however. With increased accuracy of treatment delivery comes the need for greater accuracy in target delineation and incorporation of motion to prevent marginal misses. The goal of this review is to evaluate the use of IMRT in cervical and endometrial cancers, including the results of dosimetric and clinical studies to date. In addition, potential disadvantages and challenges of IMRT integration are discussed.

Publication types

  • Review

MeSH terms

  • Endometrial Neoplasms / radiotherapy*
  • Female
  • Humans
  • Radiotherapy, Intensity-Modulated / methods
  • Uterine Cervical Neoplasms / radiotherapy*